• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Eric T. Wong, MD

Publications

  • Mahadevan A, Floyd S, Wong E, Chen C, Kasper E.Clinical outcome after Hypofractionated Stereotactic Radiotherapy (HSRT) for benign skull base tumors.Comput Aided Surg. 2011 Apr 6.
    21466421
  • Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S.Bevacizumab for recurrent glioblastoma multiforme: a meta-analysis.J Natl Compr Canc Netw. 2011 Apr;9(4):403-7.
    21464145
  • Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D, Kim S, Ye P, D'Ercole AJ, Wong ET, Lamantia AS, Walsh CA.The cerebrospinal fluid provides a proliferative niche for neural progenitor cells.Neuron. 2011 Mar 10;69(5):8
    21382550
  • Wong ET, Brem S.Taming glioblastoma by targeting angiogenesis: 3 years later.J Clin Oncol. 2011 Jan 10;29(2):124-6.
    21135277
  • Drappatz J, Norden AD, Wong ET, Doherty LM, Lafrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY.Phase I Study of Vandetanib with Radiotherapy and Temozolomide for Newly Di
    20137866
  • Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM.Updated Response Assessment Crit
    20231676
  • Wong KK, Engelman JA, Cantley LC.Targeting the PI3K signaling pathway in cancer.Curr Opin Genet Dev. 2010 Feb;20(1):87-90. Review.
    20006486
  • Park S,Zhao D,Hatanpaa KJ,Mickey BE,Saha D,Boothman DA,Story MD,Wong ET,Burma S,Georgescu MM,Rangnekar VM,Chauncey SS,Habib AA.RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop
    19435890
  • Wong ET,Huberman M,Lu XQ,Mahadevan A.Bevacizumab reverses cerebral radiation necrosis.J Clin Oncol. 2008 Dec 1;26(34):5649-50.
    18981459
  • Drappatz J,Wong ET,Schiff D,Kesari S,Batchelor TT,Doherty L,Lafrankie DC,Ramakrishna N,Weiss S,Smith ST,Ciampa A,Zimmerman J,Ostrowsky L,David K,Norden A,Barron L,Sceppa C,Black PM,Wen PY.A pilot safety study of lenalidomide and radiotherapy for patients
    18513880
  • Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, La Rosa S, Wang F, Berman SM.Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy.Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):281-9.
    18406892
  • Chowdhary S, Wong ET.Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme--improvement over available therapy?.Nat Clin Pract Neurol. 2008 May;4(5):242-3.
    18212790
  • Wong ET, Alsop D, Lee D, Tam A, Barron L, Bloom J, Gautam S, Wu JK.Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas.Cerebrospinal Fluid Res. 2008;5:1.
    18186943
  • Wu WC, Buxton RB, Wong EC.Vascular space occupancy weighted imaging with control of residual blood signal and higher contrast-to-noise ratio.IEEE Trans Med Imaging. 2007 Oct;26(10):1319-27.
    17948723
  • Wong ET, Brem S.Taming glioblastoma: targeting angiogenesis.J Clin Oncol. 2007 Oct 20;25(30):4705-6.
    17947716
  • Wong ET, Lee D, Tam A, Gautam S, Wu JK.Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis.Clin Lymphoma Myeloma. 2007 Jan;7(4):305-8.
    17324339
  • Wong ET.Is protracted low-dose temozolomide feasible in glioma patients?.Neurology. 2006 Aug 8;67(3):543-4; author reply 543-4.
    16894133
  • Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor recepto
    16424019
  • Wong ET.Tumor growth, invasion, and angiogenesis in malignant gliomas.J Neurooncol. 2006 May;77(3):295-6.
    16314946
  • Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK.Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.J Clin Oncol. 1999 Aug;17(8):2572.
    10561324